About PathXL
PathXL is a Healthcare company based in Belfast (United Kingdom) founded in 2004, and was acquired by Philips in June 2016. Web-based workflow solutions for digital pathology are developed. PathXL has raised $1.48 million across 3 funding rounds from investors including Philips, Invest Northern Ireland and Par Equity. PathXL offers products and services including ULTRA LIS, Cirdan Tutor, Solas OR XL, Path Lite+, and Core Lite. Its focus areas include HealthTech, Clinical Labs IT, Pathology and LIMS. Its legal entity is PHILIPS DCP (BELFAST) LIMITED.
Company details
PathXL was founded in 2004 in Belfast, United Kingdom. Digital pathology solutions are provided through web-based platforms, covering laboratory management, image storage, quality control, basic image analysis, and whole slide scoring for biomarker discovery. An exclusive agreement with Indica Labs enables integration of their Halo image analysis software. Operations center on tumor analysis within the oncology sector.
- Headquarters Belfast, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website pathxl.com
- Social LinkedIn X
- Acquired by Philips (Jun 2016)
- Legal Name Philips Dcp (Belfast) Limited
- Date of Incorporation 03 Feb, 2004
- Jurisdiction BELFAST, NORTHERN IRELAND
Products & Services of PathXL
PathXL offers a comprehensive portfolio of products and services, including ULTRA LIS, Cirdan Tutor, Solas OR XL, Path Lite+, and Core Lite.
Streamlines workflows with cloud-based lab management tools.
Facilitates digital learning for pathology professionals.
Provides X-ray cabinets for pathology specimen verification.
Offers complete gross imaging for laboratory use.
Enables rapid verification of breast biopsy cores.
Funding Insights of PathXL
PathXL has successfully raised a total of $1.48M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.48M
- Total Rounds 3
- First Round $1.48M
(Apr 2009)
- Investors Count 6
All 3 funding rounds of PathXL with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2012 | Series B | – | Par Equity, Clarendon Fund Managers | – | |
| Jan 2012 | Series A | – | – | ||
| Apr 2009 | $1.48M | Seed | – | – |
7 investors in total: 7 institutional.
Investors in PathXL
PathXL has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Philips, Invest Northern Ireland and Par Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital and natural capital investments are managed by Par Equity. | 2008 | parequity.com | Edinburgh, United Kingdom | |
Venture capital funding is provided to high-growth businesses. | 2001 | clarendon-fm.co.uk | Belfast, United Kingdom | |
| crescentcapital.co.uk | ||||
Qubis is engaged in commercializing academic research from Queen's University. | qubis.co.uk | Belfast, United Kingdom | ||
| e-synergy.com | ||||
Business support and investment attraction services are provided to enterprises. | 2002 | investni.com | Belfast, United Kingdom | |
Diversified products are provided across health, lighting, and consumer sectors. | 1891 | philips.com | Amsterdam, Netherlands |
Investor details for PathXL
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of PathXL
4 dated milestones of PathXL across 12 years, from founding to its latest funding, stage changes and deals.
- Founded PathXL is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Series B,.
- Exit Acquired by Philips.
Web traffic of PathXL
Websites that share an audience with PathXL (pathxl.com).
Websites whose visitors overlap most with PathXL. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| metasystems-international.com | 100% | #3,529,020 | View details | ||
| auroradx.com | 98% | 1.3K | #12,110,626 | View details | |
| cerner.com | 97% | 925.2K | #50,149 | View details | |
www3.gehealthcare.com | www3.gehealthcare.com | 97% | – | ||
| indicalab.com | 71% | #1,256,013 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for PathXL
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PathXL
PathXL was founded in 2004 and raised its 1st funding round 5 years after it was founded.
PathXL is headquartered in Belfast, United Kingdom. It is registered at Belfast, Northern Ireland, United Kingdom.
PathXL is a funded company, having raised a total of $1.48M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.48M, raised on Apr 2009.
PathXL was founded in 2004 in Belfast, United Kingdom. Digital pathology solutions are provided through web-based platforms, covering laboratory management, image storage, quality control, basic image analysis, and whole slide scoring for biomarker discovery. An exclusive agreement with Indica Labs enables integration of their Halo image analysis software. Operations center on tumor analysis within the oncology sector.
PathXL offers ULTRA LIS, Cirdan Tutor, Solas OR XL, Path Lite+, and Core Lite.
PathXL has 7 investors. Key investors include Philips, Invest Northern Ireland, Par Equity, Clarendon Fund Managers, and Crescent Capital.
PathXL operates through Philips Dcp (Belfast) Limited.
Yes. PathXL was acquired by Philips in June 2016.